Chimeric Therapeutics is a company developing ground-breaking CAR T cell therapies for solid tumors.
Chimeric Therapeutics has raised $2.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
Chimeric Therapeutics is headquartered in Carlton South, Australia.
Chimeric Therapeutics is a company developing ground-breaking CAR T cell therapies for solid tumors.
Chimeric Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Chimeric Therapeutics — Funding & Investors." VCBacked, December 23, 2025, https://www.vcbacked.co/company/chimeric-therapeutics. Accessed August 17, 2026.
VCBacked. (2025). Chimeric Therapeutics — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/chimeric-therapeutics
{{cite web |title=Chimeric Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/chimeric-therapeutics |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated